Related Experiment Video
Updated: Jul 2, 2026

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
CD40 expression on antigen presenting cells and correlation with disease severity in atopic dermatitis
Ezogelin Oflazoglu1, Eric L Simpson, Rodd Takiguchi
1Department of Preclinical Therapeutics, Seattle Genetics, Inc., Bothell, WA 98021, USA. eoflazoglu@seagen.com
European Journal of Dermatology : EJD
|August 12, 2008
Summary
This study reveals that CD40 is elevated on antigen-presenting cells (APCs) in atopic dermatitis (AD) skin lesions, correlating with disease severity. Targeting these CD40-positive APCs may offer a new therapeutic avenue for AD patients.
Area of Science:
- Immunodermatology
- Cutaneous Immunology
- Atopic Dermatitis Pathogenesis
Background:
- Atopic dermatitis (AD) involves skin inflammation, immune cell infiltration, and elevated IgE.
- Antigen-presenting cells (APCs) are crucial in AD pathogenesis.
- CD40 upregulation on inflammatory cells in AD was noted, but cell identity and disease correlation were unclear.
Purpose of the Study:
- To identify the specific cells expressing CD40 in atopic dermatitis skin lesions.
- To determine the correlation between CD40-positive cells and AD disease severity.
- To explore the relationship between CD40 expression, serum markers, and IgE levels in AD.
Main Methods:
- Analysis of CD40 expression in skin lesions and peripheral blood of AD patients.
- Immunohistochemical identification of CD40-positive cells in skin.
- Correlation analysis of CD40+ cell counts with clinical severity scores and serum markers (PARC, IgE).
Main Results:
- A positive correlation was found between the number of CD40-positive cells and AD disease severity.
- CD40 was predominantly expressed on CD1a+ and CD11b+ APCs within AD skin lesions.
- Serum PARC and IgE levels correlated with the abundance of CD40+ cells in skin.
Conclusions:
- CD40 is significantly upregulated on APCs in the skin of atopic dermatitis patients.
- The number of CD40-expressing APCs in skin lesions correlates with disease severity.
- Targeting CD40-positive APCs represents a potential therapeutic strategy for managing atopic dermatitis.
Related Concept Videos
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
